Pfizer, Gilead, GSK to lead infectious diseases market July 21, 2023 BUSINESS·HEALTH Despite a 63.8 per cent decline in forecast sales for Covid-19 drugs in 2023, infectious disease drug sales are expected to maintain Read More
